PatientsLikeMe ™

all
Skip over navigation
Join Now (It's free!)

Already a member? Log in

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.

patients

Taking Natalizumab
267 Patients currently take Natalizumab
30 Patients stopped taking Natalizumab
msladyinca
Sensation: moderate
Overall: mild
Cognition: none
Vision: none
Speech: none
Swallowing: none
Upper limb: moderate
Walking: severe
See profile
msladyinca
300 mg monthly since Oct 16, 2006
gretchensteele
Flare-up: severe
Sensation: severe
Overall: severe
Cognition: severe
Vision: moderate
Speech: severe
Swallowing: moderate
Upper limb: severe
Walking: severe
See profile
gretchensteele
Tysabri, 300 mg monthly since Dec 01, 2006
crysbo
Sensation: severe
Overall: moderate
Cognition: moderate
Vision: mild
Speech: moderate
Swallowing: moderate
Upper limb: moderate
Walking: moderate
See profile
crysbo
Tysabri, monthly since Jun 01, 2007

forum

What are people saying about Natalizumab?

There are 1487 posts in our forum about Natalizumab. Join now and see what people are saying.

Brand Names: Tysabri

What is Natalizumab? Natalizumab is a monoclonal antibody given by infusion and used in the treatment of MS and Crohn's disease. It has been shown to slow progression and reduce relapses in MS. It is currently sold under the brand name Tysabri. Read more...Click to read more below


What we've learned

Why Patients Take Natalizumab

slow my disease's progress
slow my disease's progress: 100% 228
Other
Other: 8% 19
Not indicated
Not indicated: 5% 12
Stiffness/spasticity
Stiffness/spasticity: 2% 5
General health
General health: 1% 3
Fatigue
Fatigue: 0% 1
Imbalance when walking
Imbalance when walking: 0% 1
Pain
Pain: 0% 1
Transfering
Transfering: 0% 1

Patient Dosages

1 mg monthly 4 mg monthly 5 mg monthly 15 mg monthly 20 mg monthly 25 mg monthly 30 mg monthly 50 mg monthly 100 mg monthly 200 mg monthly 300 mg monthly 1000 mg monthly N/A
2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 56 Number of Patients: 56 1 Number of Patients: 1 199 Number of Patients: 199  

How Long Current Patients Have Been Taking Natalizumab

< 1 month > 1 month > 3 months > 6 months > 1 year > 2 years
10
30
56
53
76
2

Why Patients Stopped Taking Natalizumab (multiple reasons could be selected)

Other
Other: 100% 17
Doctor's advice
Doctor's advice: 71% 12
Side effects too severe
Side effects too severe: 65% 11
Did not seem to work
Did not seem to work: 29% 5
Expense
Expense: 6% 1
Personal research
Personal research: 6% 1
Course of treatment ended
Course of treatment ended: 6% 1
Not indicated
Not indicated: 6% 1

How Long Patients Took Natalizumab Before Stopping

< 1 month > 1 month > 3 months > 6 months > 1 year > 2 years
8
8
3
8
3
1

Average: 1 star 2 star 3 star 4 star Natalizumab Ratings

4 stars4 stars4 stars4 stars
4: 100% 23
3 stars3 stars3 stars
3: 17% 4
2 stars2 stars
2: 9% 2
1 star
1: 4% 1


Back to top